ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: HTML, PDF (Size: 221K)  | Related Articles | Citation Tracking

Botox in men
Timothy Corcoran Flynn*
  *Cary Skin Center, Cary, NC and Department of Dermatology, University of North Carolina, Chapel Hill, North Carolina
Address correspondence and reprint requests to: Timothy Corcoran Flynn, MD, Cary Skin Center, PO Box 5129, Cary, NC 27512 USA, or email: flynn@caryskincenter.com.
Copyright © Blackwell Publishing, Inc., 2007
KEYWORDS
benign prostate hypertrophy • botulinum toxin • hyperhidrosis

ABSTRACT

ABSTRACT: Men have a growing interest in cosmetic dermatologic treatments. Botulinum toxin type A (BTX-A) treatment offers a minimally invasive approach to improving facial lines and is often the first cosmetic procedure chosen by male patients. In general, men can be treated with the same techniques as women, but often require more units of BTX-A. Glabellar lines in the male have been the most well-studied with a recommended starting dose of 40 U. Some men may require up to 80 U in the glabellar complex. The most common cause of an inadequate result in male patients is under-dosing. Forehead lines require care, as many men with horizontal lines have low-positioned eyebrows, and excessive relaxation of the lower frontalis muscle can drop their brows further. Special consideration should be given to the male brow when treating men. Lateral orbital lines can be treated with a starting dose of 15 U per crow's foot. Men may need additional injections to the orbicularis oculi muscle as many men have a broad circumferential orbicularis. The lower face is amenable to BTX-A treatment in men. BTX-A can be used to reduce axillary sweating and improve armpit odor. BTX-A shows promise in treating benign prostatic hyperplasia, and may in the future become a first-line treatment.


DIGITAL OBJECT IDENTIFIER (DOI)
10.1111/j.1529-8019.2007.00156.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Latest News & Information
DTH Impact Factor

Sign Up Now
Sign Up Now
Sign Up Now

Sign Up Now

Be the first to know about new research in your field

Sign up for FREE e-alerts from Wiley-Blackwell journals!

Sign Up Now